Search
Medicaid Monitor
Saturday, November 21, 2026 · Updated Fri 12:06 PM MT · 52 stories on Friday, November 20
Medicaid Monitor Pro
Sat, Nov 21 · 52 stories on Friday, November 20PRO
← All stories
IndustryMay 28, 2026

CVS Restores Lilly Obesity Drug to Formularies After Prior Removal

CVS Health has returned Eli Lilly's obesity medication to its formularies after previously removing it. This formulary reinstatement affects Medicaid managed care organizations that contract with CVS Caremark for pharmacy benefit management services, potentially expanding access to GLP-1 medications for Medicaid enrollees. The decision reverses a prior coverage restriction and may influence pharmacy spending and prior authorization protocols. Managed care plans should review their pharmacy contracts and assess budget impact from potential increased utilization of high-cost obesity treatments.

Pharmacy · Managed Care

Read the full article at statnews.com →
Share this briefing

You might also like

← All stories

Get the daily briefing.